Assertio Holdings (ASRT) - Kewajiban jangka dawa marang modal

Assertio - logo grafis emiten ASRT

Geopolitical tensions are limiting the export of neurological drugs and access to foreign substances. The ratio of long-term debt to equity allows for a risk assessment, where 0.52 serves as the base parameter value. Demand for analgesics remains stable, ensuring the business's resilience to economic cycles. Meanwhile, Assertio Holdings, Inc. (ASRT) logistics hubs and packaging capacities are operating without downtime.

assertiotx.com (ASRT): Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 27.06.2026
Produk asli Assertio Holdings

Earnings volatility at Assertio Holdings, Inc. (ASRT) driven by neurology patent risks necessitates strict control over the liability structure. This ratio correlates liabilities with maturities exceeding one year against equity. This allows for an assessment of the business's dependence on external borrowing amidst unstable cash flows. Reducing leverage ensures the company's survival during periods of declining demand. The trend of the long-term financial stability indicator regarding debt determines the issuer's margin of safety.

Analisis perusahaan pesaing

Rasio utang jangka dawa marang modal BIIB (Biogen Inc)|Utang jangka dawa marang modal NBIX|RGC - Kewajiban jangka dawa marang modal|Axsome Therapeutics - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal acadia-pharm.com ACAD|XENE - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Utang jangka dawa marang modal|Utang jangka dawa marang modal harmonybiosciences.com|Utang jangka dawa marang ekuitas Biohaven (BHVN)|Rasio tanggungan utang jangka dawa marang modal Amylyx Pharmaceuticals Inc|Utang jangka dawa marang ekuitas Trevi Pharma TRVI|Rasio tanggungan utang jangka dawa marang modal Praxis Corp (PRAX)|Anavex Life Sciences - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal ceribell.com|Prothena Corp (PRTA) - Utang jangka dawa marang ekuitas|Alector - Koefisien utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas ANNX|OMER (Omeros Corp.) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang modal NGNE|Rasio tanggungan utang jangka dawa marang modal acimmune.com|Utang jangka dawa marang ekuitas Voyager Therapeutics, Inc. VYGR|Neumora (NMRA) - Kewajiban jangka dawa marang modal|SCLX: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal TVGN (Tevogen Bio Inc.)|ACOG: Utang jangka dawa marang modal|cogrx.com - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Inhibikase Therapeutics, Inc.|Kewajiban jangka dawa marang modal Cassava Sciences Inc SAVA|Utang jangka dawa marang ekuitas Coya Therapeutics, Inc. (COYA)|Utang jangka dawa marang ekuitas VTGN (vistagen.com)|Utang jangka dawa marang modal OVID (Ovid Therapeutics)|ABOS: Rasio utang jangka dawa marang modal|CervoMed - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Alterity Therapeutics ATHE|clene.com (CLNN) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal PEPG|JUNS (Jupiter Neurosciences Inc) - Utang jangka dawa marang modal|RLMD - Tanggungan utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas Annovis Bio (ANVS)|Rasio tanggungan utang jangka dawa marang modal gracetx.com|Firefly Neuroscience Inc - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal KLTO|NeuroSense Therapeutics, Ltd. - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal revivapharma.com RVPH|metaviatx.com (MTVA) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal NRXS|HSDT (Helius Medical Technologies, Inc.) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Passage Bio Corp (PASG)|Rasio utang jangka dawa marang ekuitas NEUP (Neuphoria Therapeutics Inc.)|Rasio tanggungan utang jangka dawa marang modal minervaneurosciences.com|Utang jangka dawa marang modal ATHA (Athira Pharma)|Utang jangka dawa marang modal Addex Therapeutics Ltd. ADXN|ALZN - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Cyclerion Therapeutics CYCN|protagenic.com (PTIX) - Utang jangka dawa marang ekuitas|Pasithea Therapeutics Corp. - Koefisien utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas CRGT|ATXI (Avenue Therapeutics Inc.) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Kewajiban jangka dawa marang modal|ITCI: Rasio utang jangka dawa marang ekuitas|LBPH - Utang jangka dawa marang modal|Marinus (MRNS) - Utang jangka dawa marang ekuitas|NKGen Biotech Corp - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas NeuroBo Pharmaceuticals|Kewajiban jangka dawa marang modal sagerx.com SAGE|Utang jangka dawa marang modal SNPX|Utang jangka dawa marang modal Trevena Inc. (TRVN)|Utang jangka dawa marang ekuitas Vigil Neuroscience, Inc. VIGL|Rasio tanggungan utang jangka dawa marang modal Anew Medical Inc. (WENA)|CERE - Utang jangka dawa marang ekuitas